Wednesday Oct 30, 2024

PALTtalk Special Edition: Leading the Way Through Respiratory Virus Season

Episode: Leading the Way Through Respiratory Virus Season

Host: Ghinwa Dumyati, MD, Professor of Medicine, Director of the Communicable Diseases Surveillance and Prevention Program, University of Rochester

Guest(s): Kelly Langford, Online Communications Director for the Risk Less. Do More. Campaign, U.S. Department of Health and Human Services

In This Episode:
In this episode of PALTtalk, Dr. Ghinwa Dumyati and Kelly Langford discuss the importance of immunizations during respiratory virus season, focusing on flu, COVID-19, and RSV. They highlight the new Risk Less. Do More. campaign, which aims to reduce infection risks, especially among vulnerable populations, including older adults in long-term care facilities.

Since the recording of this episode, the Advisory Committee on Immunization Practices (ACIP) released updated COVID-19 vaccination guidance for 2024-2025. In addition to the previously recommended 2024-2025 COVID-19 vaccination, ACIP now recommends a second dose of the 2024-2025 COVID-19 vaccine for adults ages 65 and older.

  • For those who are previously unvaccinated and receiving Novavax, two doses are recommended as the initial vaccination series. This should be followed by a third dose of any age-appropriate 2024-2025 COVID-19 vaccine at least 6 months after the second dose, with a minimum interval of 2 months.

Date Recorded: October 22, 2024

Resources:
Risk Less. Do More. Campaign (HHS)
Moving Needles Project (PALTmed and CDC)
Talking with Patients About Respiratory Virus Season (CDC)

Available Credit: The American Board of Post-Acute and Long-Term Care Medicine (ABPLM) issues CMD credits for select PALTtalk podcast episodes as follows:

Credit_Designations_92424bkn7z.png

This episode is certified for CMD Clinical hours.

Claim CMD Credit

Support: Funding for this podcast was provided through the Risk Less. Do More. campaign from the U.S. Department of Health and Human Services.

Comments (0)

To leave or reply to comments, please download free Podbean or

No Comments

Copyright 2023 AMDA. All rights reserved.

Podcast Powered By Podbean

Version: 20240731